Evidence map›Paper›PMID 31441039›Full record

ArticleClinical genetics2019

A homozygous missense variant in CHRM3 associated with familial urinary bladder disease.

Glenda M Beaman, Gabriella Galatà, Keng W Teik, Jill E Urquhart, Ali Aishah, James O'Sullivan, Sanjeev S Bhaskar, Katherine A Wood, Huw B Thomas, Raymond T O'Keefe and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. HumaneLife · 2024
    Article
  2. Muscarinic control of cardiovascular function in humans: a review of current clinical evidence.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2024
    Review
  3. Expanding theFrontiers in genetics · 2022
    Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Glenda M BeamanManchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.ORCID 0000-0002-6098-9995
Gabriella GalatàManchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
Keng W TeikDepartment of Genetics, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.
Jill E UrquhartManchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
Ali AishahDepartment of Genetics, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.
James O'SullivanManchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
Sanjeev S BhaskarManchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
Katherine A WoodManchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
Huw B ThomasDivision of Evolution and Genomic Sciences, Faculty of Biology, Medicine and Human Sciences, University of Manchester, Manchester, UK.
Raymond T O'KeefeDivision of Evolution and Genomic Sciences, Faculty of Biology, Medicine and Human Sciences, University of Manchester, Manchester, UK.
Adrian S WoolfDivision of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, UK.
Helen M StuartManchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
William G NewmanManchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.ORCID 0000-0002-6382-4678
University of Manchester · GBHospital Kuala Lumpur · MYManchester Academic Health Science Centre · GBPeking University · CN

Funding

Department of Health IS-BRC-1215-20007Medical Research Council MR/L002744/1
6 · The paper itself

Abstract

CHRM3 codes for the M3 muscarinic acetylcholine receptor that is located on the surface of smooth muscle cells of the detrusor, the muscle that effects urinary voiding. Previously, we reported brothers in a family affected by a congenital prune belly-like syndrome with mydriasis due to homozygous CHRM3 frameshift variants. In this study, we describe two sisters with bladders that failed to empty completely and pupils that failed to constrict fully in response to light, who are homozygous for the missense CHRM3 variant c.352G > A; p.(Gly118Arg). Samples were not available for genotyping from their brother, who had a history of multiple urinary tract infections and underwent surgical bladder draining in the first year of life. He died at the age of 6 years. This is the first independent report of biallelic variants in CHRM3 in a family with a rare serious bladder disorder associated with mydriasis and provides important evidence of this association.

Indexed as

Base SequenceFamilyFemaleHomozygoteHumansMalaysiaMaleMutation, MissenseReceptor, Muscarinic M3Urinary Bladder DiseasesCHRM3 protein, humanReceptor, Muscarinic M3CHRM3distended bladderprune bellyurinary bladder disease

Identifiers

PMID31441039
PMCPMC6899476
OpenAlexW2967531843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.